Targeted drug delivery for musculoskeletal diseases

Affiliations

Editorial

Dong Wang et al. Adv Drug Deliv Rev. 2005.

. 2005 May 25;57(7):935-7.

doi: 10.1016/j.addr.2004.12.012. Epub 2005 Apr 19.

¹ Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah 20 S 2030 E RM 215C, Salt Lake City, UT 84112, USA. dong.wang@m.cc.utah.edu

No abstract available

Cited by

An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis.
Gupta S, Maurya MR, Stephens DL, Dennis EA, Subramaniam S. Gupta S, et al. Biophys J. 2009 Jun 3;96(11):4542-51. doi: 10.1016/j.bpj.2009.03.011. Biophys J. 2009. PMID: 19486676 Free PMC article.
Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.
Wang D, Sima M, Mosley RL, Davda JP, Tietze N, Miller SC, Gwilt PR, Kopecková P, Kopecek J. Wang D, et al. Mol Pharm. 2006 Nov-Dec;3(6):717-25. doi: 10.1021/mp0600539. Mol Pharm. 2006. PMID: 17140259 Free PMC article.
Prevention of orthopedic device-associated osteomyelitis using oxacillin-containing biomineral-binding liposomes.
Liu XM, Zhang Y, Chen F, Khutsishvili I, Fehringer EV, Marky LA, Bayles KW, Wang D. Liu XM, et al. Pharm Res. 2012 Nov;29(11):3169-79. doi: 10.1007/s11095-012-0812-7. Epub 2012 Jun 26. Pharm Res. 2012. PMID: 22733150 Free PMC article.